复方倍他米松联合盐酸利多卡因辅助治疗突发性聋的疗效观察

doi:10.6040/j.issn.1673-3770.0.2017.508

摘要/Abstract

摘要： 目的探讨复方倍他米松联合盐酸利多卡因耳后乳突骨膜下注射治疗突发性聋的疗效。方法对2015年5月至2017年5月间收治的基础治疗方案相同、资料完整的100例单耳伴耳鸣的突发性聋病例进行回顾性研究和统计学分析。按其在基础治疗基础上是否给予复方倍他米松联合盐酸利多卡因耳后乳突骨膜下注射分为注射组50例和非注射组50例。对比治疗前后患者纯音听阈曲线,取0.25~4 kHz听力平均值,对听力提高分贝数进行对比;同时对患者耳鸣改善情况进行对比。结果听力疗效:注射组治愈10 例(20% ),显效 20例(40%),有效13例(26%),无效7例(14%);非注射组治愈5例(10%),显效10例(20%),有效18例(36%),无效17例(34%);耳鸣疗效:注射组治愈10例(20%),有效15例(30%),无效25例(50%);非注射组治愈6例(12%),有效13例(26%),无效31例(62%)。结论复方倍他米松联合盐酸利多卡因耳后局部注射,对突发性聋患者听力改善具有临床意义。

关键词: 耳后注射, 复方倍他米松, 盐酸利多卡因, 聋, 突发性

Abstract: Objective To investigate the effect of postauricular mastoid subperiosteal injection with betamethasone and lidocaine hydrochloride for idiopathic sudden deafness. Methods A 100 cases of idiopathic sudden deafness with concomitant tinnitus reported at the Henan Province Peoples Hospital between May 2015 and May 2016 were retrospectively studied. These cases were divided into the injection group(50 cases)and non-injection group(50 cases). The pure tone audiometry thresholds across 0.25-4 kHz and tinnitus levels of patients were evaluated before and after treatment. Results Based on audiometry measurements, in the injection group, 10 cases(20%)were cured, 20(40%)showed good effect, 13(26%)showed moderate effect, and 7(14%)showed no effect, whereas in the non-injection group, 5 cases(10%)were cured, 10(20%)showed good effect, 18(36%)showed moderate effect, and 17(34%)showed no effect. Tinnitus evaluation indicated that, in the injection group, 10 cases(20%)were cured, 15(30%)showed good effect, and 25(50%)showed no effect, whereas in the non-injection group, 6 cases(12%)were cured, 13(26%)showed good effect, and 31(62%)showed no effect. Conclusion The study found that postauricular mastoid subperiosteal injection with betamethasone and lidocaine hydrochloride was beneficial for patients with idiopathic sudden deafness.

Key words: Ears after injection, Deafness, sudden, Compound betamethasone, Lidocaine hydrochloride

中图分类号:

R764

黄颖铭,万保罗,靳钰炜. 复方倍他米松联合盐酸利多卡因辅助治疗突发性聋的疗效观察[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 11-13.

HUANG Yingming, WAN Baoluo, JIN Yuwei. Clinical efficacy of postauricular mastoid subperiosteal injection with betamethasone and lidocaine hydrochloride[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 11-13.

参考文献

[1] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会. 突发性耳聋诊断和治疗指南(2015)[J].中华耳鼻咽喉头颈外科杂志,2015,50(6):443-447.
[2] 彭玉成,符涛,孙爱华,等. 弥可保和维生素B₁₂穴位注射治疗神经性耳鸣疗效观察[J].中国中西医结合耳鼻咽喉科杂志,2001,9(5):217. PENG Yucheng, FU Tao, SUN Aihua, et al. A comparative study on the therapeutic effect of acupoint injection to neurogenic tinnitus with methycobal[J]. Chin J Otorhinolaryngol Integr Med, 2001, 9(5):217.
[3] 李玲,黄志纯,陶锋. 突发性耳聋治疗及预后相关因素的研究进展[J]. 东南大学学报(医学版),2013,32(3):350-353.
[4] 杨晓琦,余力生,马鑫. 耳后注射复方倍他米松治疗顽固性低频型感音神经性聋[J].中华耳鼻咽喉头颈外科杂志,2007(42):814-815. YANG Xiaoqi, YU Lisheng, MA Xin. Postaurical injection of compound betamethasone to treat the intractable low-frequency sensorineural hearing loss[J]. Chin J Otorhinolaryngol Head Neck Surg, 2007(42):814-815.
[5] 李媚. 复方倍他米松联合山莨菪碱治疗突发性耳聋的疗效观察与护理[J].中国误诊学杂志,2014,11(11):2552.
[6] Jun HJ, Chang J, Im GJ, et al. Analysis of frequency loss as a prognostic factor in idiopathic sensorineural hearing loss[J]. Acta Otolaryngol, 2012,4(12):1-7.
[7] Morris L, Collins M. A patient with unilateral idiopathic sudden sensorineural hearing loss[J]. JAAPA, 2013, 26(1):32,34-35.
[8] 吴小娟,李和. 辅以利多卡因的穴位注射治疗主观性耳鸣临床观察[J]. 四川中医,2017,35(8):189-191.
[9] 王薇,黄鹤年. 利多卡因治疗耳鸣[J].国外医学耳鼻咽喉科学分册,1985,9(3):117.
[10] Noushi F, Richardson RT, Hardman J, et al. Dedlivery of neurotrophin-3 to the cochlea using alginate beads[J]. Otol Neurotol, 2005, 26(3):528-533.
[11] Endo T, Nakagawa T, Kita T, et al. Novel strategy for treatment of inner ears using a biodegradable gel[J]. Laryngoscope, 2005, 115(11):2016-2020.
[12] Li J, Yu L, Xia R, et al. Postauricular hypodermic injection to treat inner ear disorders: experimental feasibility study using magnetic resonance imaging and pharmacokinetic comparison[J]. J Laryngol Otol, 2013, 127(3):239-245.

相关文章 15

[1]	王莹,蔡燕文. 以听力减退为主要表现的中枢神经系统表面铁沉积症1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 89-96.
[2]	郑泽皓,魏佳俐,刘嘉涛,周玉麒,孙文婷,李雨轩,白鹏. 特定部位针刺法治疗突发性聋的疗效及安全性评价:一项系统综述和网状Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 114-127.
[3]	李洁,苏维娜,林倩,张奇舒,侯成,杨振娇,相丽丽. 两例耳聋病例中MARVELD2基因变异的遗传学分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 128-134.
[4]	林育珊,卢标清. 巴曲酶个性化用药治疗全频下降型突聋[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 115-121.
[5]	王鑫,原晶晶,郝鹏鹏,闫占峰,刘建华,钟利群,刘思溟,吴薇,赵晓阳,张莹. 中药复方治疗突发性聋的疗效和可能机制:一项结合网络药理学研究的回顾性临床分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 6-17.
[6]	郭翔,马永强,伊海金. 突发性聋磁共振检查的现状与进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 140-144.
[7]	李培培,卢彦青,侯楠. 机器学习预测模型在突发性聋中的临床应用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 145-151.
[8]	陈丹萍,何子键,虞幼军,周晓娓. 儿童突发性聋10年住院病例的疗效及预后相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 16-22.
[9]	李钰,刘皓,王敏,付小龙,李文. mTOR通路在耳蜗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 112-118.
[10]	曹影,邱月,陈智斌,费兵,李东,张晓凤,王惠,康欣乐,王海旭,怀德,李秀婷,束明阳. 难治性突聋耳后注射神经节苷脂联合鼓室内注射甲泼尼龙治疗前后言语识别率及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 15-21.
[11]	周静,毕秀丽,肖雨,胡俊,付小龙,于亚峰. 盐酸氯米帕明保护听觉毛细胞免受新霉素诱导的损伤[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 22-27.
[12]	梁俊杰,张佳佳,张琳婧,孟言,李阳,白鹏. 中西医结合治疗突发性聋合并手足口病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 91-95.
[13]	张晓,刘海红,刘薇,李颖,陈敏,刘冰,白杰,张杰,郑军,杨扬. 先天性单侧聋患儿112例临床资料分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 96-196.
[14]	张佳佳,石安妮,邢御,洪玉颖,白鹏. 针刺联合西药治疗全聋型突发性聋1例与文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 88-92.
[15]	杨旻,朱晓燕,王旭. 感音神经性聋的代谢组学研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 113-121.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed